上海迪赛诺医药集团股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
34
NMPA:34
Drug Approvals
Lamivudine and Tenofovir Disoproxil Fumarate Tablets
- Product Name
- 拉米夫定替诺福韦片
- Approval Number
- 国药准字H20249842
- Approval Date
- Dec 25, 2024
NMPA
Avatrombopag Maleate Tablets
- Product Name
- 马来酸阿伐曲泊帕片
- Approval Number
- 国药准字H20249585
- Approval Date
- Dec 1, 2024
NMPA
Lopinavir and Ritonavir Tablets
- Product Name
- 洛匹那韦利托那韦片
- Approval Number
- 国药准字H20247241
- Approval Date
- Oct 14, 2024
NMPA
Tedizolid Phosphate Tablets
- Product Name
- 磷酸特地唑胺片
- Approval Number
- 国药准字H20234508
- Approval Date
- Nov 21, 2023
NMPA
Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets（Ⅰ）
- Product Name
- 依非米替片(Ⅰ)
- Approval Number
- 国药准字H20233988
- Approval Date
- Aug 1, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- Next
Clinical Trials
No trials found
News
No news found